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Platelet-derived growth factor is constitutively secreted from
neuronal cell bodies but not from axons
Marcus Fruttiger*, Andrew R. Calver† and William D. Richardson*
Neurons synthesise and secrete many growth and
survival factors but it is not usually clear whether they
are released locally at the cell body or further afield
from axons or axon terminals. Without this information,
we cannot predict the site(s) of action or the biological
functions of many neuron-derived factors. For example,
can neuronal platelet-derived growth factor (PDGF) be
secreted from axons and reach glial cells in nerve-fibre
(white-matter) tracts? To address this question, we
expressed PDGF-A in retinal ganglion neurons in
transgenic mice and tested for release of PDGF from cell
bodies in the retina and from axons in the optic nerve.
In both the retina and optic nerve, there are glial cells
that express PDGF receptor α (PDGFRα) [1] and divide
in response to PDGF [2–5], so we could detect
functional PDGF indirectly through the mitogenic
response of glia at both locations. Expressing PDGF-A
in neurons under the control of the neuron-specific
enolase promoter (NSE–PDGF-A) resulted in a striking
hyperplasia of retinal astrocytes, demonstrating that
PDGF is secreted from the cell bodies of neurons in the
retina [4]. In contrast, glial proliferation in the optic
nerve was unaffected, indicating that PDGF is not
released from axons. When PDGF was expressed
directly in the optic nerve under the control of an
astrocyte-specific promoter (GFAP–PDGF-A),
oligodendrocyte progenitors hyperproliferated, resulting
in a hypertrophic optic nerve. We conclude that PDGF is
constitutively secreted from neuronal cell bodies in vivo,
but not from axons in white-matter tracts.
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Results and discussion
Retinal ganglion cells (RGCs) — the neurons that project
axons through the optic nerve — express PDGF-A [1] but
it is not known whether they target PDGF to their axons
or, if so, whether they can release PDGF into the nerve.
Resident optic nerve astrocytes also synthesise PDGF-A
[1]. It is difficult to establish whether RGCs or optic nerve
astrocytes normally deliver PDGF-AA (the secreted dimer
of PDGF-A) to the optic nerve because growth factors
typically act at low concentrations and are difficult to trace
once they are released into the extracellular milieu. We
bypassed this difficulty by using a physiological measure of
PDGF activity in vivo. We overexpressed PDGF-A either
in neurons or astrocytes in transgenic mice and studied the
proliferative response of PDGF-responsive glial cells. We
monitored oligodendrocyte progenitors (OLPs) in the optic
nerve and astrocytes in the retina; both these cell types
express PDGFRα [1], allowing us to identify and count
them by in situ hybridisation with a PDGFRα probe.
The pre-existing NSE–hPDGF-A transgenic mice [4,6]
express human PDGF-A under the control of the mouse
NSE promoter (Figure 1). In case human PDGF-AA
might be targeted or secreted abnormally in mouse cells,
we generated a new line that overexpresses mouse
PDGF-A (NSE–mPDGF-A). We also generated control
mice expressing human PDGF-A in astrocytes under the
Figure 1
Possible sites of PDGF-A release in transgenic mice. Cells carrying the
PDGFRα are drawn in blue and PDGF-AA-secreting cells are in red.
(a) Overexpression of PDGF-A (yellow) under the control of the NSE
promoter resulted in neuron-specific expression, whereas (b) the
GFAP promoter directed transgene expression to astrocytes. Note that
retinal astrocytes express PDGFRα but not PDGF-A, whereas optic
nerve astrocytes express PDGF-A but not PDGFRα [1].
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mouse GFAP promoter (GFAP–hPDGF-A; Figure 1). In
NSE–hPDGF-A mice, hPDGF-A was expressed by RGCs
and cells in the inner nuclear layer of the retina (Figure 2b
and [4]), and in GFAP–hPDGF-A mice the transgene was
expressed in retinal astrocytes (Figure 2c). The effects of
the transgene in the retina were analysed by visualising
retinal astrocytes by in situ hybridisation with a probe
against PDGFRα. In all transgenic mouse strains, there
was marked hyperplasia of retinal astrocytes (Figure 2f–h).
In NSE–hPDGF-A and NSE–mPDGF-A mice, this reflected
PDGF-AA release from RGC cell bodies, resulting in a
paracrine neuron–astrocyte interaction in the retina.
This confirms that the transgene is secreted in an active
form by RGCs. In GFAP–hPDGF-A mice, a PDGF-
AA–PDGFRα autocrine loop is created in retinal astro-
cytes themselves.
We confirmed by in situ hybridisation that in
NSE–hPDGF-A P1 mice there was no production of trans-
genic PDGF-A mRNA in the optic nerve (Figure 3b). This
was as expected, as there are no resident neurons in the
nerve. In contrast, we found strong transgene expression
by optic nerve astrocytes in GFAP–hPDGF-A mice
(Figure 3c), again as expected. At P1, proliferating OLPs
are just starting to populate the optic nerve by inward
migration from the brain through the optic chiasm [1].
Therefore, we analysed OLP numbers in the optic nerve
at P7, by which time the nerve is normally full of OLPs
[1]. We visualised OLPs in the optic nerve by in situ
hybridisation for PDGFRα. No increase of OLP numbers
could be detected in the optic nerves of either
NSE–hPDGF-A or NSE–mPDGF-A mice (Figure 3f,h),
suggesting that no extra PDGF is released into the optic
nerves of these mice. In contrast, we found a dramatic
increase of PDGFRα+ OLP numbers in the optic nerves of
GFAP–hPDGF-A mice compared with wild-type litter-
mates (Figure 3g). Counting OLPs in optic nerve cross
sections revealed no differences between wild-type (average
25 ± 2), NSE–hPDGF-A (24 ± 2) or NSE–mPDGF-A (24 ± 3)
mice but about a threefold increase in GFAP–hPDGF-A
mice (77 ± 8; see Materials and methods). This was accom-
panied by a marked increase in the diameter of the optic
nerve (Figure 3g). Closer inspection by electron microscopy
revealed that this size increase resulted from an increase
of oligodendrocyte lineage cells, with no increase in the
number of optic nerve astrocytes (W. Blakemore, personal
communication). This was as expected because optic nerve
astrocytes do not express PDGFRα.
It was possible that a slight increase in OLP numbers
might not have been detected against the normal back-
ground of OLPs in wild-type nerves. We therefore investi-
gated the effect of the NSE–hPDGF-A transgene in
PDGF-A null mice [7], which have almost no OLPs in
their optic nerves (Figure 4b), as a result of which they
remain practically unmyelinated [5]. We crossed the
NSE–hPDGF-A transgene into the PDGF-A null back-
ground but this did not result in any rescue of OLP
numbers in the optic nerve whatsoever (Figure 4d). As a
control, we analysed OLPs in the spinal cord, which, in
contrast to the optic nerve, contains neuronal cell bodies
as well as axon tracts. As previously reported, there were
increased numbers of progenitor cells in spinal cords of
NSE–hPDGF-A mice compared with wild-type mice ([6]
and Figure 4e,g). In PDGF-A null mice, there were very
few OLPs (< 5% of normal; [5,6] and Figure 4f). On top of
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Figure 2
Hyperplasia of retinal astrocytes indicates the presence of transgenic
PDGF-A in the retina. Cross sections of retinae from (a–d) 1 day old
(P1) and (e–h) 5 day old (P5) mice that were (a,e) wild type, or
expressed the (b,f) NSE–hPDGF-A, (c,g) GFAP–hPDGF-A or
(d,h) NSE–mPDGF-A transgenes. The sections were probed for
expression of (a–d) human PDGF-A or (e–h) PDGFRα. In (c), note the
retinal astrocytes expressing human PDGF-A (arrow). In (d), note that
the probe against human PDGF-A does not recognise endogenous
mouse PDGF-A. Retinal astrocytes displayed hyperplasia in
(f–h) transgenic mice, but not in (e) wild-type mice. The scale bar in
(h) represents 200 µm.
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this background, the NSE–hPDGF-A transgene restored
OLP numbers in the spinal cord (Figure 4h). Most of the
OLPs were in the central grey matter of the cord where
the neuronal cell soma are located. This confirms that
transgene-derived PDGF-AA can be released from
neurons and can stimulate OLP division.
Our results indicate that PDGF-AA is released from neu-
ronal cell bodies but not from axons. This is consistent
with the fact that cultured endothelial cells secrete
PDGF-BB almost exclusively from the basal surface [8], as
the basolateral domain of endothelial cells is thought to be
equivalent to the somatodendritic region of neurons. It
therefore appears that, in the optic nerve, OLP proliferation
is entirely dependent on astrocyte-derived PDGF-AA.
This conclusion is also supported by the fact that intraocu-
lar injection of colchicine, which blocks fast axonal trans-
port, does not affect OLP proliferation in the optic nerve
[9]. On the other hand, blocking electrical activity in RGC
axons inhibits OLP proliferation in the optic nerve [10].
Taking that result together with the data described here it
seems likely that, as suggested by Barres and Raff [11], an
activity-dependent signal from RGC axons stimulates the
secretion of mitogens, including PDGF-AA, from astrocytes
in the optic nerve.
Brief Communication 1285
Figure 3
Transgenic PDGF-A increases OLP numbers in the optic nerve only in
GFAP–PDGF-A but not in NSE–PDGF-A mice. Cross-sections
through the optic nerves of (a,e) wild-type mice, or mice expressing the
(b,f) NSE–hPDGF-A, (c,g) GFAP–hPDGF-A or (d,h) NSE–mPDGF-A
transgenes. (a–d) In situ hybridisation with a probe against human
PDGF-A confirmed the presence of transgene mRNA in the optic nerve
of (c) GFAP–hPDGF-A mice but not in (b) NSE–hPDGF-A or in
(d) NSE–mPDGF-A mice. (e–h) OLPs, visualised by in situ
hybridisation with a mouse PDGFRα probe, were increased in number
in (g) GFAP–hPDGF-A mice but not in (f) NSE–hPDGF-A or
(h) NSE–mPDGF-A mice. There was no difference between the
numbers of PDGFRα+ cells per section in (e,f,h) but there was a large
increase in (g). The scale bar in (h) represents 200 µm.
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Figure 4
In PDGF-A null mice, transgenic PDGF-A expressed in neurons can
restore OLP numbers in the spinal cord (which contains both axons and
neuronal cell bodies) but not in the optic nerve (which contains axons
but no cell bodies). (a–d) In situ hybridisation with a probe against
PDGFRα to visualise OLPs in longitudinal sections of P5 optic nerves.
The entire length of the optic nerve was reconstructed from several
adjacent sections. In (a) wild-type mice, the optic nerve was populated
by PDGFRα+ OLPs, whereas they were absent from the optic nerve of
(b) PDGF-A null mice, in spite of some PDGFRα+ cells being present in
the optic chiasm (arrow). Transgene-derived hPDGF-A expressed in
neurons did not reach OLPs in the optic nerve, as there was no increase
in the number of optic nerve OLPs in NSE–PDGF-A transgenic mice
either in the (c) presence or (d) absence of endogenous PDGF-A (that
is, wild-type or PDGF-A null background). (e–h) In contrast, transgenic
hPDGF-A from neurons was able to reach OLPs in the spinal cord, as
the presence of the NSE–PDGF-A transgene increased OLP numbers
in a wild-type background (compare panels e and g) and restored near-
normal OLP numbers to the PDGF-A null background (compare panels
f and h). These data are consistent with PDGF-A release from neuronal
cell bodies in the spinal cord but not from axons in the optic nerve. The
scale bars in (d,h) represent 200 µm.
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There is immunohistochemical evidence that PDGF is
present in growth cones of neurons in the developing
CNS [12]. This implies that PDGF is transported in an
anterograde direction along axons. We were previously
unable to detect PDGF-A immunoreactivity in RGC
axons in the optic nerve although very weak immunoreac-
tivity was present in RGC cell bodies and proximal axons
in the retina [1]. Our failure to detect PDGF in optic
nerve axons might have been a technical problem result-
ing from low concentrations of PDGF, or it might have
been due to epitope masking by protein–protein interac-
tions. In any case, our present data demonstrate that, even
if PDGF is transported through the optic nerve, it is not
released from axons during transit. Other diffusible
polypeptides, for example brain-derived neurotrophic
factor (BDNF), are believed to be transported in an
anterograde direction along axons and to be secreted from
nerve terminals [13,14]. It will be interesting and impor-
tant to determine how transport occurs and whether it is
generally true that such factors are prevented from being
released into axon tracts. This would have major implica-
tions for neuron–glial interactions in white-matter tracts.
Materials and methods
Transgenic mice
Production of NSE–hPDGF-A mice has been described [4].
NSE–mPDGF-A and GFAP–hPDGF-A mice were produced accord-
ing to standard techniques [15]. The NSE–mPDGF-A transgene was
constructed by replacing hPDGF with mPDGF [16] in the
NSE–hPDGF-A vector. The GFAP–hPDGF-A transgene contains the
GFAP promoter [17] and a human PDGF-A cDNA engineered to
encode the ‘short’ alternative-splice isoform [18]. The hPDGF-A cDNA
was taken from the same plasmid that was used for production of the
NSE–hPDGF-A mice [4]. Five GFAP–PDGF-A founder mice were pro-
duced, of which two died before reaching sexual maturity. The remain-
ing three founders were used to establish lines. The observable
phenotypes were indistinguishable in all three lines (data not shown)
but the results described in this paper are derived from one line only.
With the NSE–mPDGF-A transgene, four founder mice were created.
One of them expressed the transgene and was used to establish a line.
In situ hybridisation and quantification of OLP numbers
Cryosections were processed for in situ hybridisation with digoxigenin-
labelled probes (human PDGF-A and mouse PDGFRα) as described
previously [5]. OLPs were counted in five cross-sections of optic
nerves from three different mice of each genotype and expressed as
mean and standard deviation for each genotype.
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